Tallinn, Estonia, 2017-11-07 13:15 CET (GLOBE NEWSWIRE) --
Listing and Surveillance Committee of Nasdaq Tallinn decided on October 5, 2017 to refuse admission to trading of AS Medical Pharmacy Group B-shares on MTF First North operated by Nasdaq Tallinn AS. Respective decision is available here: https://cns.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=804154&messageId=1009605
AS Medical Pharmacy Group has submitted an appeal to the Arbitration Court of Tallinn Stock Exchange on November 3, 2017, with the claims as follows:
- Deem the refusal decision adopted on October 5, 2017 by Listing and Surveillance Committee of Nasdaq Tallinn to be unlawful;
- Recognize that AS Medical Pharmacy Group B-shares are applicable to be admitted to trading on multilateral trading facility First North operated by Nasdaq Tallinn and to force Nasdaq Tallinn AS to admit AS Medical Pharmacy Group B-shares to trading on multilateral trading facility First North operated by Nasdaq Tallinn AS;
- Leave procedural expenses to be paid by Nasdaq Tallinn.
Nasdaq Tallinn will announce the decision of Arbitration Court in a separate market announcement as soon as possible.
Nasdaq Baltic
Issuer Services
+372 640 8800
www.nasdaqbaltic.com
Nasdaq Baltic is a common name for exchanges, regulated markets, alternative markets First North operated by Nasdaq companies in the Baltic states, i.e. Nasdaq Tallinn AS, Nasdaq Riga AS and AB Nasdaq Vilnius.